Inventiva SA (IVA) News & Events

$4.705

-0.187 (-3.98%)At close

IVA News

9.507-29seekingalpha

Inventiva S.A. 1H 2026 Financial Overview

8.506-02NASDAQ.COM

Inventiva S.A. Halts Trading for Financing

9.505-27seekingalpha

Inventiva S.A. Reports No Revenue for Q1 2026

9.503-30seekingalpha

Inventiva S.A. Reports FY GAAP EPS and Revenue Decline

2.011-28Benzinga

Tilray Brands, SuperX AI Technology, and Other Major Stocks Decline in Friday's Pre-Market Trading

2.011-28Benzinga

Heartbeam Shares Surge Approximately 43%; Check Out 20 Stocks Making Moves in Premarket Trading

9.011-28Globenewswire

Inventiva's Shareholders' Meeting Approves All Resolutions Except for the 5th One

2.011-24Benzinga

Novo Nordisk, Waldencast, and Other Major Stocks Decline in Pre-Market Trading on Monday

9.511-24Benzinga

LexinFintech Shares Surge Over 15%; Check Out 20 Stocks Making Moves in Premarket Trading

2.010-29Benzinga

Major Stocks Including Mondelez International, Stride, and Varonis Systems Decline in Wednesday's Pre-Market Trading

Show More News

IVA Events

7/10 09:00

Draganfly Borrow Rate Increases to 15.28%

Latest data shows the largest indicative borrow rate increases among liquid option names include: Draganfly (DPRO) 15.28% +2.94, KULR Technology Group (KULR) 26.19% +2.30, Defiance Daily Target 2x Long OKLO ETF (OKLL) 15.06% +2.17, REalloys Inc (ALOY) 49.95% +1.81, Sunbelt Rentals Holdings Inc (SUNB) 2.29% +1.48, Canadian Solar (CSIQ) 3.41% +0.70, Global X CyberSecurity ETF (BUG) 2.97% +0.53, Quantum Computing (QUBT) 14.07% +0.52, Inventiva SA (IVA) 1.67% +0.49, and MSOX ETF (MSOX) 5.04% +0.42.

4/22 16:10

Inventiva Appoints New Leadership Team Members

Inventiva (IVA) announced three new members of its leadership team: Axel-Sven Malkomes as CFO, Susan Coles as chief legal officer, and Pamela Herbster as chief people officer. Former CFO Jean Volatier will transition to the role of EVP finance and corporate social responsibility, where he will continue to support the company on strategic priorities. Malkomes was most recently CFO at publicly CureVac (CVAC). Coles comes to Inventiva from Vivet Therapeutics, where she was head of legal and finance. Herbster comes to Inventiva from Sage Therapeutics, where she led both human resources and business operations.

11/13 09:31

Inventiva Prices 32.47M Share Spot Secondary at $3.85

Leerink and Piper Sandler acted as joint book running managers for the offering.

11/12 16:46

Inventiva Announces Offering of $125M in American Depositary Shares

Inventiva announced that it plans to offer and sell approximatively $125M of new American Depositary shares, or ADSs, each representing one new ordinary share of the company, in an underwritten public offering in the United States only. The company's ADSs are listed on the Nasdaq Global Market under the ticker symbol "IVA" and the company's ordinary shares are listed on the regulated market of Euronext in Paris under the symbol "IVA". All securities to be sold in the offering will be offered solely by the company. The company intends to use the net proceeds from the offering, together with existing cash and cash equivalents, mainly to fund the continuation of the company's NATiV3 Phase 3 clinical trial as well as the continuation of the preparation and initiation of the outcome trial and for commercialization activities, working capital and general corporate purposes. Leerink Partners and Piper Sandler are acting as underwriters for the offering.

Show More Events

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.